Technical Analysis for GSD - Devonian Health Group Inc

Grade Last Price % Change Price Change
D 0.220 0.00% 0.000
GSD closed down 12.0 percent on Tuesday, April 9, 2024, on 11 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Flat

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -12.00%
Wide Bands Range Expansion -12.00%
Overbought Stochastic Strength -12.00%
Narrow Range Bar Range Contraction -12.00%
Stochastic Reached Overbought Strength -12.00%
Wide Bands Range Expansion -12.00%

   Recent Intraday Alerts

Alert Time
Down 1 ATR 11 days ago
Fell Below Previous Day's Low 11 days ago
Down 5% 11 days ago
Down 3% 11 days ago
Down 2% 11 days ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, which is in Phase IIa clinical trials for the treatment of ulcerative colitis and atopic dermatitis. The company also develops value-added products for dermo-cosmetics, and distributes pharmaceutical products. In addition, it acquires drug and health product licenses. Devonian Health Group Inc. has a strategic alliance with CannTx Life Sciences Inc. for the development of cannabinoid-based pharmaceutical drugs. The company was incorporated in 2013 and is headquartered in Québec, Canada.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharma Pharmaceutical Clinic Drug Science Drugs Life Sciences Health Sciences Pharmaceutical Products Clinical Trial Cannabinoid Pharmaceutical Industry Medication Ulcer Cosmetics Pharmaceutical Sciences Atopic Dermatitis Colitis Pharmaceutical Drugs Ulcerative Colitis

Is GSD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.68
52 Week Low 0.11
Average Volume 18,589
200-Day Moving Average 0.315
50-Day Moving Average 0.178
20-Day Moving Average 0.199
10-Day Moving Average 0.220
Average True Range 0.020
RSI (14) 54.34
ADX 19.37
+DI 41.366
-DI 28.566
Chandelier Exit (Long, 3 ATRs) 0.190
Chandelier Exit (Short, 3 ATRs) 0.185
Upper Bollinger Bands 0.274
Lower Bollinger Band 0.123
Percent B (%b) 0.64
BandWidth 76.171
MACD Line 0.015
MACD Signal Line 0.012
MACD Histogram 0.003
Fundamentals Value
Market Cap 13.81 Million
Num Shares 62.8 Million
EPS -0.05
Price-to-Earnings (P/E) Ratio -4.58
Price-to-Sales 3.69
Price-to-Book 1.16
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.220
Resistance 3 (R3) 0.220 0.220 0.220
Resistance 2 (R2) 0.220 0.220 0.220 0.220
Resistance 1 (R1) 0.220 0.220 0.220 0.220 0.220
Pivot Point 0.220 0.220 0.220 0.220 0.220
Support 1 (S1) 0.220 0.220 0.220 0.220 0.220
Support 2 (S2) 0.220 0.220 0.220 0.220
Support 3 (S3) 0.220 0.220 0.220
Support 4 (S4) 0.220